U.S. Professional Services Stock News

If you are wondering whether Corteva stock still offers value at around US$75.71 per share, the key question is how its current price compares with its underlying fundamentals. The share price has eased slightly over the past week and is down about 7.9% over the last month, yet it remains up 11.7% year to date and 3.0% over the past year, with a 36.7% return over three years and 84.1% over five years. Recent coverage around Corteva has focused on its position within the broader chemicals...

In recent days, EchoStar completed multi-billion-dollar spectrum sale agreements with SpaceX and AT&T, receiving a mix of cash, SpaceX stock, and interest-payment support while also confronting liquidity concerns after its DISH DBS unit skipped an interest payment and entered a grace-period default. These moves have effectively tied EchoStar’s fortunes more closely to SpaceX’s newly public valuation and the execution of large spectrum transactions, while options trading and sector capital...

Earlier in June 2026, Xylem Inc. announced a long-term agreement to design, build and operate advanced water treatment and reuse systems for Dow’s large industrial complex in Fort Saskatchewan, Alberta, while Dow began notifying employees of approximately 4,500 layoffs under its Transform to Outperform cost program. Together, the workforce reductions and the Alberta water reuse project highlight how Dow is reshaping both its cost base and its approach to resource efficiency and environmental...

Anyone interested in World Acceptance Corporation ( NASDAQ:WRLD ) should probably be aware that the Senior VP, Luke...

A 2X leveraged ETF like SPCU aims to double the daily move of the SpaceX trade. But there is more than meets the eye in how that works, and the details are worth knowing.

Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...

Helen of Troy Limited ( NASDAQ:HELE ), might not be a large cap stock, but it received a lot of attention from a...

Ligand Pharmaceuticals (LGND) has drawn fresh attention after recent trading, with the stock last closing at US$253.25. For investors, the focus now is on how this biopharmaceutical licensing model aligns with their portfolio goals. See our latest analysis for Ligand Pharmaceuticals. The recent 1 day share price decline of 0.90% to US$253.25 comes after a strong run, with a 30 day share price return of 18.78% and a 1 year total shareholder return of 120.20%, suggesting momentum has been...

If you are wondering whether Datadog stock is offering value at current levels, it helps to separate the recent share price excitement from what the fundamentals might support. Datadog last closed at US$233.09, with returns of 0.6% over 7 days, 12.1% over 30 days, 74.2% year to date, 91.2% over 1 year, 143.4% over 3 years and 127.7% over 5 years. These figures naturally raise questions about what is already reflected in the price. Recent coverage around Datadog has focused on its role in...

Muted stock reaction to new battery order Enovix (ENVX) recently announced a new battery order, but the stock reaction has been muted as investors weigh ongoing concerns about sustained demand and slow progress in drone battery applications over recent quarters. See our latest analysis for Enovix. Against this muted reaction to the new order, Enovix’s recent share price performance has been mixed, with a 46.28% 90 day share price return but a year to date share price decline of 10.27% and a 1...

Earlier in June 2026, REX American Resources filed a US$69.00 million shelf registration for 1,500,000 common shares tied to an ESOP-related offering, while also reporting record Q1 2026 earnings per share of US$0.56 that exceeded expectations despite softer revenue. The board’s approval of a new Restricted Stock Unit Award Agreement under the 2026 Incentive Plan highlights an increased focus on equity-based compensation to align employees with long-term corporate objectives. Next, we’ll...

Axsome Therapeutics presented new Phase 3 data on AXS-12 in narcolepsy at a major sleep medicine conference. The company also shared Phase 3 and post hoc analyses on solriamfetol related to sleep disorders such as sleep apnea. These presentations focus on central nervous system conditions and add fresh clinical detail to Axsome Therapeutics' late stage pipeline. Axsome Therapeutics (NasdaqGM:AXSM) is drawing attention after releasing new Phase 3 and post hoc data on AXS-12 and solriamfetol...

If you are wondering whether LiveRamp Holdings stock still offers value at its current price, the key is understanding what the recent share performance says about expectations built into the valuation. The stock last closed at US$37.57, with returns of 0.2% over 7 days, 26.7% over 30 days, 37.0% year to date, 18.4% over 1 year, 44.4% over 3 years, and a decline of 10.5% over 5 years, which gives mixed signals about how the market has priced the company over different time frames. Recent...

Prestige Consumer Healthcare (PBH) is back in focus after fiscal 2026 earnings missed estimates, revenue declined year over year, and guidance for fiscal 2027 came in below consensus expectations. See our latest analysis for Prestige Consumer Healthcare. Those weaker fiscal 2026 results, cautious fiscal 2027 guidance, and the new investor investigation have coincided with a sharp loss of momentum, with Prestige Consumer Healthcare’s share price down 25.1% over 90 days and its 1 year total...

Fiserv (NasdaqGS:FISV) has announced an abrupt CEO transition, with Takis Georgakopoulos appointed to replace Mike Lyons. Lyons is leaving the company after just over a year in the role to join Truist Financial. The leadership change follows sustained pressure from activist investor Jana Partners and comes during major operational and portfolio shifts. Fiserv is making this leadership change while its share price stands at $47.91 and longer term returns have been weak, with the stock down...

Outlook Therapeutics previously secured FDA acceptance of its resubmitted Biologics License Application for ONS-5010/Lytenava, following a successful appeal that confirmed substantial evidence of effectiveness and removed the requirement for new clinical trials. The FDA’s Class 1 review with a roughly 60-day PDUFA timeline, combined with ongoing launches in Europe and the UK, places Lytenava at the center of Outlook Therapeutics’ path toward broader commercial reach. We’ll now examine how...

Williams-Sonoma (NYSE:WSM) has launched the GreenRow x NYBG home collection in collaboration with the New York Botanical Garden. The collection features sustainable home textiles and décor inspired by botanical artwork from NYBG’s historical archives. The partnership supports NYBG’s plant science mission while expanding Williams-Sonoma’s presence in environmentally focused home design. For investors tracking Williams-Sonoma, the GreenRow x NYBG launch adds context to a stock that has seen...

Graphic Packaging Holding (GPK) stock is in focus after a wave of securities class action filings and investigations alleging misleading disclosures on inventory issues, demand trends, costs, and business strength. See our latest analysis for Graphic Packaging Holding. Graphic Packaging Holding’s share price has bounced in the short term, with a 1‑month share price return of 13.8% and 3‑month return of 11.8%. However, longer term performance remains weak, with the 1‑year total shareholder...

The Morning Bull - US Market Morning Update Tuesday, Jun, 16 2026 US stock futures are pointing higher this morning, with E-mini S&P 500 contracts up about 2.1% and Nasdaq-100 futures ahead roughly 3.2%, as investors respond to a sharp pullback in government bond yields and lower oil prices tied to a US Iran peace framework. The US 10 year yield sits near 4.43%, a one month low that can ease pressure on mortgages, credit cards, and corporate borrowing. At the same time, Michigan consumer...

Nexstar Media Group (NXST) stock is back in focus after the company reported first quarter 2026 earnings and revenue that surpassed Wall Street expectations, along with several senior leadership promotions. See our latest analysis for Nexstar Media Group. Despite the first quarter 2026 beat and leadership promotions, Nexstar Media Group’s short term share price performance has been weak. The share price is down 11.82% over 30 days and 27.55% over 90 days, even as the 1 year total shareholder...

Heartland Express, Inc.’s board previously declared a regular quarterly cash dividend of US$0.02 per share, paid on July 6, 2026, to shareholders of record as of June 23, 2026. This payment represented the company’s ninety-second consecutive quarterly cash dividend, underscoring a long-running commitment to returning cash to shareholders even as operations face pressure. Next, we’ll examine how this long streak of quarterly dividends fits into Heartland Express’s investment narrative amid...

Dividend momentum puts Hancock Whitney stock in focus Hancock Whitney (HWC) is drawing attention after recent commentary highlighted its 2.8% dividend yield, which is higher than both the Banks - Southeast industry and the S&P 500, alongside an increased annualized dividend. With the company raising dividends three times over the past five years and projecting earnings growth of 12.24% for fiscal 2026, investors are reassessing how Hancock Whitney stock fits into income and total-return...

Fox Corp’s US$22b cash and stock move to acquire Roku has pushed streaming and digital media stocks back into the spotlight, with investors reassessing who might gain most from a reshaped connected TV market. With Fox shares down 8% in early trading and Roku stock halted ahead of the news, pricing expectations and deal risk are suddenly front and center. This article walks through 3 stocks from the Streaming and Digital Media Stocks screener that are directly exposed to this Fox and Roku...

On June 2, 2026, Zions Bancorporation, N.A. expanded its Board of Directors from 11 to 12 members and elected retired PwC partner Daniel J. Ryan to fill the new seat, also appointing him to the Audit and Risk Oversight Committees effective July 1, 2026. Ryan’s four decades advising major banks on governance, risk management, and regulatory issues signal an intensified focus on oversight and controls at Zions. Next, we’ll examine how adding a seasoned audit and risk expert to the board could...